Stem Cell Play Organicell (BPSR) Screams Higher.
Stock Levitates After Series of Positive Press Releases on Zofrin.
Added to the Watch List in April a...
American BriVision (ABVC) Reports Completion Clinical Trial for Treatment of Adult ADHD.
American BriVision (ABVC) Reports Completion of ABV-1505 Phase II Part I Clinical Trial for Treatment of Adult ADHD.
Last...
The Resurgence Of Selling Shareholders In Microcap IPOs
Forbes Finance Council
In today’s capital markets landscape, the initial public offering market is experiencing significant challenges, especially for...
Psychedelics CURED My Alcoholism
RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober.
Psychedelics CURED...
Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...
Two Binary Events Directly Ahead.
As in Months Away, not Years. Share Price up 76% During April.
Telehealth App Hapbee (HAPB) Goes Public and More.
1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...
Doubling Down After ATAI’s (ATAI) Anti Depression Treatment Bombs in Front of FDA.
Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm.
Atai was founded in...
Popular Wellness Wearable Band, Hapbee (HAPB), Launches New Signal “Bedtime.”
Hapbee Completes Development of First New Signal Based on User-feedback and Market Demand; Plans to Launch More Signals this Year
And We Have Our First MEME Stock! $2.00 to $29.95.
Tiny U.S. Biotech Jumps 930% as It Picks Up Retail Attention (Bloomberg)
Guess we were bound to stumble across...
Video: Okay, You Tested Positive for Corona, Now What?
https://youtu.be/vN30emwcNS4
Professor Roger Seheult,...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
